Filing Details

Accession Number:
0000950170-24-026428
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 18:00:14
Reporting Period:
2024-03-04
Accepted Time:
2024-03-05 18:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1653087 Alector Inc. ALEC Biological Products, (No Disgnostic Substances) (2836) 822933343
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1895592 Sara Kenkare-Mitra C/O Alector, Inc.
131 Oyster Point Blvd., Suite 600
South San Francisco CA 94080
President And Head Of R&D No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-04 10,169 $6.92 318,847 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.9217 to $6.9218. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.